18th Annual European Life Sciences CEO Forum

FOR PARTNERING & INVESTMENT

26th - 27th of February 2025|HILTON ZURICH AIRPORT HOTEL | SWITZERLAND

Sachs Associates would like to say that we have enjoyed hosting you in-person and virtually and thank those who participated in our 18th Annual European Life Sciences CEO Forum (Sachs_ELSF). A special thank you goes to the excellent line-up of sponsors, chairs, panellists, and presenters who made such a broad and interesting programme possible.

The ELSF has proven to be successful in supporting our community with over 430 people from 27 countries registered and nearly 2000 in-person & online meetings completed.   

Publicly available recordings of the sessions and presentations from the event will be uploaded to the SachsTV YouTube channel in April. 

We are looking forward to welcoming you again to our future events!

SILVER SPONSOR:

Stifel

BRONZE SPONSORS:

InvestHK
Lilly and Company

CONTRIBUTING SPONSORS:

Cancer Research Horizons
Novo Holdings A/S

Presenting Companies Included:

AATec Medical GmbH logo
Abalos Therapeutics GmbH logo
ActiTrexx GmbH logo
Alder Therapeutics AB logo
Alpioner Therapeutics logo
AM-Pharma B.V. logo
Amporin Pharmaceuticals AG logo
Anixa Biosciences, Inc. logo
ANNIMO Health EDC AG
Anocca AB logo
Antabio SAS
ARTCLINE GmbH logo
AVEROA SAS logo
BioInvent International AB logo
biotx.ai GmbH logo
brainQr Therapeutics GmbH logo
CIS BIOPHARMA AG logo
CNS Pharmaceuticals, Inc. logo
Convert Pharmaceuticals SA logo
FluoSphera SA logo
FoRx Therapeutics AG logo
Galimedix Therapeutics, Inc. logo
HHC Medical logo
In Virtuo Laboratories SAGL logo
Innovent Biologics logo
invIOs GmbH logo
iOmx Therapeutics AG logo
Laverock Therapeutics Ltd. logo
Lead Pharma Medicine B.V. logo
LightOx Ltd. logo
LimmaTech Biologics AG logo
Mabylon AG logo
Macomics Ltd. logo
MetrioPharm AG logo
MicThera SAGL logo
Mighto Therapeutics logo
MitoRx Therapeutics logo
NatIgGs GmbH logo
NEC Bio B.V. logo
OncoBone Therapeutics Ltd
PannTheraPi logo
PhoreMost Ltd. logo
Procavea Biotech AG
Reconnect Labs AG logo
RedHill Biopharma Ltd.
Sapreme Technologies BV logo
Sarcura GmbH logo
Scarlet Therapeutics Limited logo
Serenatis Bio logo
Spago Nanomedical AB logo
SpikImm SARL logo
SpyBiotech Inc. logo
STIMIT AG logo
Stromal Therapeutics AG logo
T-knife Therapeutics
Telum Therapeutics SL logo
TME Pharma logo
VasoDynamics Ltd. logo
Vectiopep logo
ViaNautis Bio Ltd. logo
XYone Therapeutics Inc. logo

Confirmed Keynote Speakers Included:

Darren Ji
Co-Founder, Chairman & CEO, Elpiscience Biopharmaceuticals Co. Ltd.

Speakers and Chairs Included:

Esteban Pombo-Villar
Board Member, TargImmune Therapeutics AG
Evonne Sepsis
Managing Director, ESC Advisors
Gregor Macdonald
VP, Head of BD & Licensing, Search & Assessment, H. Lundbeck A/S
Gregory Rall
Deputy Head, Innovation & Technology, InvestHK
Katya Smirnyagina
Senior Partner, Oxford Science Enterprises
Marc-Olivier Turgeon
Senior Associate, Forbion
Michael Hübner
Director External Scientific Innovation, Johnson & Johnson Innovation LLC
Olav Zilian
Medical Advisor, FluoSphera SA
Ole Mensching
Co-Founder & General Partner, Apollo Health Ventures
Rainer Strohmenger
Managing Partner, Wellington Partners
Rainer Metzger
Chief Business Officer, Sanavia Oncology
Regina Hodits
Managing Director, Angelini Ventures S.p.A.
Sarah Holland
President of Swiss Healthcare Licensing Group & CBO, CDR-Life AG
Stephanie Léouzon
Managing Director & Vice Chair of European Healthcare Investment Banking, Stifel
Søren Møller
Managing Partner, Novo Holdings A/S
Tim Lohoff
Senior Associate, Forbion
Victoria English
Co-Founder & Editor, Evernow Publishing Ltd, publisher of MedNous
Alain Martelli
Director, External Science Lead, Europe, Pfizer Inc.
Albert Seymour
President & CEO, Seamless Therapeutics, Inc.
Alexander Gebauer
Co-Founder & Executive Chairman, Galimedix Therapeutics, Inc.
Andreas Pahl
CEO, Heidelberg Pharma AG
Anne Grahl
Associate, Pureos Bioventures
Avencia Sanchez-Mejias García
Co-Founder & CEO, Integra Therapeutics
Boris Bogdan
Lead HCLS EMEA, Amazon Web Services
Bryan Kobel
CEO, TC BioPharm Limited
Cem Baydar
Chief Investment Officer & Board Member, Afendis Capital Management
Chandra Leo
Investment Advisor, HBM Partners AG
Charlie Bailey
BD&L Transactions Head, Global Health, Novartis AG
Darren Ji
Co-Founder, Chairman & CEO, Elpiscience Biopharmaceuticals Co. Ltd.
David Venables
CEO, Laverock Therapeutics Ltd.
Davor Kosanic
CEO, Reconnect Labs AG
Diana Pignalosa
Head of Strategic Partnering, Search & Evaluation, Debiopharm International SA
Esther Melo
Senior Director BD&L, F. Hoffmann-La Roche AG
George Tzircotis
Associate Director, BD, Cancer Research Horizons
Georgia Frost
Vice President, Dementia Discovery Fund 2 L.P. (SV Health Investors)
Jeremy Griggs
Executive Director, Search & Evaluation, GSK
Jesus Baena
BD&L Transactions Oncology Director, Novartis AG
Johannes Virkkunen
Head of Division - Equity Investments, European Investment Fund
Karen Wagner
Managing Partner, Ysios Capital
Katharina Kreymborg
SVP, Curie.Bio
Konstantin Petropoulos
CEO, Secarna Pharmaceuticals GmbH & Co. KG
Laura Lane
VP Lilly Ventures - Head of Europe, Eli Lilly and Company
Marc Martinell
Co-Founder & CEO, Minoryx Therapeutics
Maria Dahl
COO & Head of Europe, Innovent Biologics
Michael Altorfer
CEO, Swiss Biotech Association
Monika Paule
Co-Founder, CEO & Board Member, Caszyme, LLC
Neil Torbett
CEO, PhoreMost Ltd.
Nikolay Savchuk
Managing Partner, Torrey Pines Investment
Paolo Di Giorgio
Managing Director & CEO, Angelini Ventures S.p.A.
Patrick Schwab
Senior Director, AI & Machine Learning, GSK
Paul Vogel
Managing Director & VP of Research, AIRNA Corporation, Inc.
Paul Hermant
Partner, Bird & Bird (Belgium) LLP
Peter Llewellyn-Davies
CEO & CFO, invIOs GmbH
Raj Airey
Founding Partner, Convergence Partners
Reagan Jarvis
Co-Founder & CEO, Anocca AB
Robert de Jonge
SVP, Head of Corporate Development, Mestag Therapeutics Ltd.
Sean Kendall
Partner, ARCH Venture Partners
Stephan Lensky
COO & CBO, EpimAb Biotherapeutics
Sylvie Ryckebusch
CBO, BioInvent International AB
Tamas Schweighoffer
Co-Founding Partner, Forty51 Ventures AG
Ted Fjällman
CEO, Flerie Invest AB
Thibaut Roulon
Senior Investment Director, Bpifrance
Thierry Laugel
Managing Partner, Kurma Partners
Thilo Schroeder
Managing Partner, Nextech Invest Ltd.
Ulrich Wendt
Global Head Business Development Immunology & Inflammation, Sanofi
Vanessa King
CEO, King Bioventures
Victor Ma
Partner, Fontaine Capital